Comparison of the Quantiplex version 3.0 assay and a sensitized amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples

35Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study evaluated correlation and agreement between version 3 of the Quantiplex human immunodeficiency virus type 1 (HIV-1) RNA assay (v3 branched DNA [bDNA]) and a sensitized Amplicor HIV.1 Monitor assay (reverse transcription [RT]-PCR) for the measurement of HIV RNA. Three hundred eighteen samples from 59 randomly selected, HIV-1-seropositive persons on various drug protocols from the National Institute of Allergy and Infectious Diseases HIV outpatient clinic were studied. The results indicate that v3 bDNA and RT-PCR are highly correlated (r = 0.98) and are in good agreement (mean difference in log10 copies/ml ± 2 standard deviations = 0.072 ± 0.371). The relationship between values obtained by both assays is given by the following equation: log10v3 bDNA = -0.0915 + 1.0052 · log10RT-PCR. This represents a 1.026-fold difference between log10RT-PCR values and log10v3 bDNA values.

Cite

CITATION STYLE

APA

Highbarger, H. C., Alvord, W. G., Jiang, M. K., Shah, A. S., Metcalf, J. A., Lane, H. C., & Dewar, R. L. (1999). Comparison of the Quantiplex version 3.0 assay and a sensitized amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples. Journal of Clinical Microbiology, 37(11), 3612–3614. https://doi.org/10.1128/jcm.37.11.3612-3614.1999

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free